Biotech · Private company · Pittsburgh, PA, US
Consegna Pharma, Inc.
Track this companyFree. Adds Consegna Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- IND-enabling development of a long-duration antagonist to treat opioid overdoseFiscal year 2025 · $377.8KNIH RePORTER 5R44DA050386-04 · fetched Nov 12, 2026
- IND-enabling development of a long-duration antagonist to treat opioid overdoseFiscal year 2024 · $837.4KNIH RePORTER 5R44DA050386-03 · fetched Nov 12, 2026